I. INTRODUCTION
Venous air embolism (VAE) is hazardous when occurring in large quantity during surgery. It can occur through an opened vein with pressure being lower than ambient, causing air to be sucked into the circulatory system. It causes injury primarily by obstruction of blood flow from the right side of the heart to the left, resulting in considerable hypoxemia from mismatched ventilation-perfusion. With large amount of emboli, systemic hypotension, myocardial ischemia, and arrhythmia occur and can result in death.
sensitive and non-invasive methods for detecting VAE [ 1-31, but it requires constant attention of anesthesiologists listening to subtle changes in the Doppler heart sound (DHS). Besides, it cannot provide the volume of air entering the heart chamber. Such information is crucial as anesthesiologists usually act only when clinically significant embolic air volume is present [4] .
Common clinical research studies generally focused on the sensitivity of PDU method towards VAE [ 1-3,571 while only Precordial Doppler ultrasound (PDU) is one of the most very limited works were devoted to DHS signal processing for VAE detection. Pattern recognition algorithms [8, 91 were applied to DHS signals for detecting VAE, which allowed unattended operation with sensitivity comparable to human observers. However, estimation of embolic air volume seems to be a difficult task as hardly any detailed research work on this aspect can be found.
In view of the above situation, we developed a fast detection algorithm with good sensitivity (down to 0.01 ml of air) using wavelet transform of DHS [lo] . With further development and modification of this algorithm [ I l l , we managed to implement it as a real-time monitor for detecting VAE [12] . Using this monitor, we studied the performance of VAE detection during sub-clinical bolus injection and clinically significant continuous infusion of air in dogs [ 131.
In the present study, we actually estimated the volume of embolic air during several simulated periods of clinically significant VAE with different air dosage based on the calibration curves derived from prior injections of subclinically small air volumes. We also demonstrated that the air dosage of prior sub-clinical injections can be reduced to as low as 0.20 ml (0.80 ml in our previous studies) in order to minimize the adverse effect (if any) on the dogs.
MATERIALS AND METHODS
The study was approved by the Animal Research Committee of the Veterans General Hospital-Taipei. Three mongrel dogs weighing 11.67 k 2.08 kg were anesthetized with pentobarbital (40 m a g , i.v.) and placed in the supine position for the experiment. The trachea was intubated with a cuffed tracheal tube using vecuronium (0.1 mgkg, i.v.) and the lungs were ventilated by a mechanical ventilator (Model 34RH, Harvard Apparatus, Natick, MA). The tidal volume was set at 15 to 20 mlkg. Rectal temperature was controlled at 37 f 1 "C using a heating lamp and 0.9 % normal saline in 5 % glucose solution was infused (3 ml kg-' h-', i.v.) to maintain a normal body fluid status. Cardiac rhythm was monitored by lead I1 electrocardiograph (Model 90601A, SpaceLab, Redmond, WA).
A 16-gauge Teflon catheter (Arrow International, Reading, PA) was inserted via the right external jugular vein for air 0-7803-5164-9/98/$10.00 0 1998 IEEE infusion. Generous quantity of coupling gel (Aquasonic 100, Parker Lab, Orange, NJ) was applied thoroughly to the circular face of the PDU probe (Model P81, 2.4 MHz, VERSATONE@ Doppler, MedaSonics, Fremont, CA), which was then pressed against the shaved skin at the right lateral border of the sternum. The correct placement of the probe over the heart was confirmed by a clearly audible sound of turbulence induced by rapid injection of 10-ml normal saline into the external jugular vein via the catheter. Micropore tapes were used to secure the probe over the chest. The line output of the PDU machine was connected to a tape recorder (WM-D6C, Sony Corp., Japan) for recording the DHS during the entire experiment. The overall frequency response of the recording system was flat (+ 3 dB) from 20 Hz to I8 kHz.
After obtaining a 5-min control baseline period of DHS, a series of sub-clinically small boluses of air (0.01, 0.015, 0.02, 0.03, 0.04, 0.05, 0.07, 0.10, 0.15, 0.20 ml) were injected into the external jugular vein through the catheter. Each injection was made by means of a microsyringe (Hamilton, Reno, NV) at 1-min interval. In order to increase the reliability and accuracy, injection for each dosage was repeated four times. After a 10-min stabilization period, a series of large air volume (2.00, 3.20, 4.80 ml) were infused gradually, each lasting for 5 min, so as to simulate a series of clinically significant VAE of different volumes. Intermissions of 3 min were allowed betweein successive infusions. The 5-min interval for each infusion was divided into twenty 15-sec intervals and appropriate dosage (0.10, 0.16, 0.24 ml) was injected gradually over these 15-sec intervals. For example, injecting 0.16 ml of air gradually over 15-sec interval for twenty times would give a simulation period of 3.20 ml of air infused over 5 min. The DHS signals produced by this infusion protocol corresponded closely to those encountered during actual clinical VAE, as confirmed by an experienced anesthesiologist (PWL;,.
The DHS signals recorded were then fed to our real-time monitor for analysis and processing [12, 131. Briefly, these signals were firstly digitized at 4 kHz, 16-bit resolution. Then, they were processed using the Daubechies 20-coefficient wavelets [ 141, which in effect suppressed the signal power of the normal DHS and enhanced those of the embolic DHS at successive scales of the wavelet transform. For each subject, the embolic DHS signall powers (embolic power in short) due to each sub-clinical bolus air injection were evaluated (repeated 4 times), and their mean (arithmetic mean (AM) and geometric mean (GIM)) were then computed. Linear regression and correlation analyses were performed on the volume of injected air and the corresponding mean embolic power. Finally, the series of embolic power data accumulated for each simulated period of clinically significant VAE in each subject were fittisd to the corresponding linear trends (calibration curves) for volume estimation. processed DHS signals is shown in Fig. 1 . Although the approximations (A1 and A2) grossly resembled the original DHS signals, the details (D1 and D2) showed striking features distinguishing embolic DHS from the normal. Essentially, the contrast of embolic to normal DHS signal power became greatly enhanced, facilitating detection and extraction of embolic power by simple thresholding. The quality of this differentiation for I91 easily exceeded that of D2, but the latter was also useful for confirming the detection made by the former. Fig. 2 shows the embolic power variation of the original DHS signals, D1, and D2 in Fig. 1 For each subject, linear relationship of good correlation coefficient was obtained in log-log scale (natural log) between the sub-clinical volume of injected air and the corresponding embolic power computed from the D 1 signals. The resulting GM calibration curves of the three subjects in this study are plotted in Fig. 3 , and the linear regression and correlation results of the AM and GM cases are listed in Table 1 . The small relative error (i.e., standard deviation divided by mean) of the slope and intercept, and the high correlation coefficient suggested the small inter-animal variation and the reliability of the present wavelet transform method, respectively. Table 1 . Linear regression results for the AM and GM calibration curves in Fig. 3 . Abbreviation: SD = standard deviation; RE = relative error; r = correlation coefficient.
The results of volume estimation using the AM calibration curves for the simulated clinically significant VAE periods of the three dogs are shown in Fig. 4 , and the numerical results of the AM and GM cases are listed in Table 2 . In general, we obtained reasonable estimation for all the cases, and particularly good estimation for the 2.00 ml cases. The estimation results due to the AM and GM calibration curves were comparable. Table 2 . Numerical results of the volume estimation and the corresponding relative error of estimation using the AM and GM calibration curves for the three dogs.
I v . DISCUSSION AND CONCLUSION
As the linear relationship between the embolic power and the volume of injected air is in log-log scale, the averaging of the repeated data samples at each air dosage may seem to be more appropriate to use not only the traditional arithmetic mean, but also the geometric mean. In fact, both of them provide comparable volume estimation results while the latter gives better correlation coefficient and lower relative error with the three subjects in this study, as evident in Table 1 .
Previously, our largest volume of sub-clinical bolus air injection was 0.80 ml in order to study the feasibility of using these bolus calibration curves for estimating clinically significant volume of embolic air [l2, 131. In the present study, we limit this larglest bolus dosage to as low as 0.20 ml while we still achieve reasonable volume estimation results. In reality, this largest bolus dosage should be brought down to as low as possible so as to minimize the adverse effect (if any) on the subjects.
The volume estimation results of the 2.00-ml case for all the three subjects in this study are particularly outstanding, while there are some irregularities in the 3.20 and 4.80-ml cases. For each subject, the 2.00-ml case is the first case in the series of simulated clinically significant VAE, which is followed by the 3.20 and 4.80-ml cases. The former case is thus performed without prior contamination of clinically significant VAE. The outstanding volume estimation performance of this case implies that our method of estimating clinically significant embolic air volume using calibration curves derived form prior sub-clinical bolus air injection is basically valid. The irregularities of the latter cases may probably be due to two main reasons. Some portion of the infused air may invariably be split into so tiny bubbles that cannot be detected by the PDU system, resulting in under-estimation. Re-circulation of air bubbles within the heart chamber as well as after the systemic circulation may contribute to over-estimation of embolic air volume. Larger volume of infused air may also provide higher possibility of embolic air re-circulation. In these aspects, there is a need to construct a mathematical model for the above effects in order to remedy the observed irregularities.
In conclusion, the wavelet transform of the DHS signals greatly enhanced the contrast of embolic to normal DHS signal power, facilitating automatic detection and extraction of embolic DHS simply by thresholding. Besides, the linear relationship obtained between the sub-clinical volume of injected air and the corresponding embolic power for a subject was shown to be capable of estimating clinically significant volume of embolic air for the same subject. Essentially, the two main shortcomings of the PDU method for diagnosing VAE, namely, the need of constant human attention for VAE detection and the lack of quantitative information on the voluine of embolic air, can be successfully overcome by the preseni wavelet transform method.
